Anti-suicidal Effects of Buprenorphine In Depressed Individuals

Summary

This study aims to examine the effect of low-dose buprenorphine as an add-on to treatment-as-usual for suicidal ideation in individuals with major depression, and investigate the functional brain activity related to its potential anti-suicidal effect.

Timeline

Start

2022-10-10

Primary completion

2024-01-14

Completion

2024-01-14

Outcome

Outcome not reported

Stopped (Enrollment): “U.S. Department of Health and Human Services OHRP issued an FWA restriction on NYSPI research that included a pause of human subjects research as of June 23, 2023. This study will not resume recruitment after the resumption of research.”

Drugs

Indications